Genetic therapy of human neoplastic disease

A. B. Deisseroth; E. G. Hanania; S. Fu; D. Claxton; M. Andreeff; R. Champlin; J. Kavanagh; G. Hortobagyi; F. Holmes; C. Reading; Ki Hong Waun Ki Hong; S. Kornblau; C. Logothetis; M. Talpaz; H. Kantarjian; W. Benedict

doi:10.1089/scd.1.1993.2.373

Genetic therapy of human neoplastic disease

A. B. Deisseroth, E. G. Hanania, S. Fu, D. Claxton, M. Andreeff, R. Champlin, J. Kavanagh, G. Hortobagyi, F. Holmes, C. Reading, Ki Hong Waun Ki Hong, S. Kornblau, C. Logothetis, M. Talpaz, H. Kantarjian, W. Benedict

Research output: Contribution to journal › Article › peer-review

Abstract

Molecular biology has provided clinical investigators and basic scientists with the tools to identify those changes present within neoplastic hematopoietic and epithelial cells that lead to the evolution of unregulated patterns of cell growth. This information has made possible the development of therapy that involves genetic modification of either the normal hematopoietic cells (for chemoprotection), or the tumor cells themselves to suppress the growth of these cells. This article will summarize the clinical and laboratory data that is evolving in this area.

Original language	English (US)
Pages (from-to)	373-375
Number of pages	3
Journal	Journal of Hematotherapy
Volume	2
Issue number	3
DOIs	https://doi.org/10.1089/scd.1.1993.2.373
State	Published - 1993

ASJC Scopus subject areas

Immunology
Hematology

Access to Document

10.1089/scd.1.1993.2.373

Cite this

@article{0816adeb3f4e4bcda6deca3f32cacbdb,

title = "Genetic therapy of human neoplastic disease",

abstract = "Molecular biology has provided clinical investigators and basic scientists with the tools to identify those changes present within neoplastic hematopoietic and epithelial cells that lead to the evolution of unregulated patterns of cell growth. This information has made possible the development of therapy that involves genetic modification of either the normal hematopoietic cells (for chemoprotection), or the tumor cells themselves to suppress the growth of these cells. This article will summarize the clinical and laboratory data that is evolving in this area.",

author = "Deisseroth, {A. B.} and Hanania, {E. G.} and S. Fu and D. Claxton and M. Andreeff and R. Champlin and J. Kavanagh and G. Hortobagyi and F. Holmes and C. Reading and {Waun Ki Hong}, {Ki Hong} and S. Kornblau and C. Logothetis and M. Talpaz and H. Kantarjian and W. Benedict",

year = "1993",

doi = "10.1089/scd.1.1993.2.373",

language = "English (US)",

volume = "2",

pages = "373--375",

journal = "Journal of Hematotherapy",

issn = "1061-6128",

publisher = "Mary Ann Liebert Inc.",

number = "3",

}

TY - JOUR

T1 - Genetic therapy of human neoplastic disease

AU - Deisseroth, A. B.

AU - Hanania, E. G.

AU - Fu, S.

AU - Claxton, D.

AU - Andreeff, M.

AU - Champlin, R.

AU - Kavanagh, J.

AU - Hortobagyi, G.

AU - Holmes, F.

AU - Reading, C.

AU - Waun Ki Hong, Ki Hong

AU - Kornblau, S.

AU - Logothetis, C.

AU - Talpaz, M.

AU - Kantarjian, H.

AU - Benedict, W.

PY - 1993

Y1 - 1993

N2 - Molecular biology has provided clinical investigators and basic scientists with the tools to identify those changes present within neoplastic hematopoietic and epithelial cells that lead to the evolution of unregulated patterns of cell growth. This information has made possible the development of therapy that involves genetic modification of either the normal hematopoietic cells (for chemoprotection), or the tumor cells themselves to suppress the growth of these cells. This article will summarize the clinical and laboratory data that is evolving in this area.

AB - Molecular biology has provided clinical investigators and basic scientists with the tools to identify those changes present within neoplastic hematopoietic and epithelial cells that lead to the evolution of unregulated patterns of cell growth. This information has made possible the development of therapy that involves genetic modification of either the normal hematopoietic cells (for chemoprotection), or the tumor cells themselves to suppress the growth of these cells. This article will summarize the clinical and laboratory data that is evolving in this area.

UR - http://www.scopus.com/inward/record.url?scp=0027818556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027818556&partnerID=8YFLogxK

U2 - 10.1089/scd.1.1993.2.373

DO - 10.1089/scd.1.1993.2.373

M3 - Article

C2 - 7921999

AN - SCOPUS:0027818556

SN - 1061-6128

VL - 2

SP - 373

EP - 375

JO - Journal of Hematotherapy

JF - Journal of Hematotherapy

IS - 3

ER -

Genetic therapy of human neoplastic disease

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this